Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression

被引:41
|
作者
Stanzione, R
Picascia, A
Chieffi, P
Imbimbo, C
Palmieri, A
Mirone, V
Staibano, S
Franco, R
De Rosa, G
Schlessinger, J
Tramontano, D
机构
[1] Univ Naples Federico II, Dipartimento Biol & Patol Mol & Cellulare Luigi C, I-80131 Naples, Italy
[2] Univ Naples Federico II, Ctr Endocrinol & Oncol Sperimentale, CNR, I-80131 Naples, Italy
[3] Univ Naples Federico II, Urol Clin, I-80131 Naples, Italy
[4] Univ Naples Federico II, Dipartimento Sci Biomorfol & Funz, Sez Patol, I-80131 Naples, Italy
[5] Univ Sannio, Fac Sci, Benevento, Italy
[6] Univ Catanzaro Magna Graecia, Dipartimento Med Sperimentale & Clin Gaetano Salv, Catanzaro, Italy
[7] NYU Med Ctr, Dept Pharmacol, New York, NY 10016 USA
关键词
D O I
10.1038/labinvest.3780211
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Proline-rich kinase 2 (Pyk2), also known as CAK beta (cell adhesion kinase beta), is a cytoplasmic tyrosine kinase that is structurally related to focal adhesion kinase. Pyk2 is expressed in different cell types including brain cells, fibroblasts, platelets, and other hemopoietic cells. Pyk2 is rapidly tyrosine phosphorylated in response to diverse extracellular signals acting via different post receptor pathways. We have investigated whether this protein kinase is functionally expressed in normal and neoplastic prostate tissues. In this study, we demonstrate that Pyk2 is expressed only in normal epithelial prostate tissue and in benign prostatic hyperplasia, whereas its expression progressively declines with an increasing grade of malignancy of prostate cancer.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 50 条
  • [1] Regulation of cell morphology by proline-rich tyrosine kinase Pyk2
    Dikic, I
    Haglund, K
    Ivankovic-Dikic, I
    PERIODICUM BIOLOGORUM, 2002, 104 (01) : 11 - 18
  • [2] The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence
    C K Sun
    K T Ng
    B S Sun
    J W Y Ho
    T K Lee
    I Ng
    R T P Poon
    C M Lo
    C L Liu
    K Man
    S T Fan
    British Journal of Cancer, 2007, 97 : 50 - 57
  • [3] The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence
    Sun, C. K.
    Ng, K. T.
    Sun, B. S.
    Ho, J. W. Y.
    Lee, T. K.
    Ng, I.
    Poon, R. T. P.
    Lo, C. M.
    Liu, C. L.
    Man, K.
    Fan, S. T.
    BRITISH JOURNAL OF CANCER, 2007, 97 (01) : 50 - 57
  • [4] Proline-rich tyrosine kinase Pyk2 regulates deep vein thrombosis
    Momi, Stefania
    Canino, Jessica
    Vismara, Mauro
    Galgano, Luca
    Falcinelli, Emanuela
    Guglielmini, Giuseppe
    Taranta, Giulia Ciarrocca
    Guidetti, Gianni Francesco
    Gresele, Paolo
    Torti, Mauro
    Canobbio, Ilaria
    HAEMATOLOGICA, 2022, 107 (06) : 1374 - 1383
  • [5] Role of proline-rich tyrosine kinase 2 (Pyk2) in the pathogenesis of Alzheimer's disease
    Kumar, Rahul
    Tiwari, Vishvanath
    Dey, Sharmistha
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2022, 56 (09) : 5442 - 5452
  • [6] Possible Involvement Of Proline-rich Tyrosine Kinase 2 (pyk2) In The Pathogenesis Of Kawasaki Disease
    Suzuki, Chinatsu
    Nakamura, Akihiro
    Okigaki, Mitsuhiko
    Miura, Noriko
    Ohno, Naohito
    Yahata, Tomoyo
    Okamoto, Akiko
    Yoshioka, Ayako
    Kuchitsu, Yuki
    Ikeda, Kazuyuki
    Hamaoka, Kenji
    CIRCULATION, 2015, 131
  • [7] Possible Involvement Of Proline-rich Tyrosine Kinase 2 (pyk2) In The Pathogenesis Of Kawasaki Disease
    Suzuki, Chinatsu
    Nakamura, Akihiro
    Okigaki, Mitsuhiko
    Miura, Noriko
    Ohno, Naohito
    Yahata, Tomoyo
    Okamoto, Akiko
    Yoshioka, Ayako
    Kuchitsu, Yuki
    Ikeda, Kazuyuki
    Hamaoka, Kenji
    CIRCULATION, 2015, 131
  • [8] Potential of Proline-rich tyrosine kinase 2 (Pyk2) as a therapeutic target for Kawasaki disease
    Hamaoka, K.
    Suzuki, C.
    Hamaoka-Okamoto, A.
    Yahata, T.
    Nakamura, A.
    Ikeda, K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 300 - 300
  • [9] Overexpression of proline-rich tyrosine kinase PYK2 induces apoptosis in small cell lung cancer cells
    Chubanov, V
    Roelle, S
    Stöppler, H
    Gudermann, T
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R22 - R22
  • [10] Pivotal roles of regulating the proline-rich tyrosine kinase 2 (PYK2) signaling in cardiac function and remodeling
    Takeishi, Yasuchika
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2014, 74 : 295 - 296